Release Date: 08/03/12 19:33 Summary: Satisfaction of Condition Precedent - Sale of NT Assets Price Sensitive: Yes Download Document 90.54KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling